GE HealthCare Technologies (NASDAQ:GEHC) Shares Gap Up Following Better-Than-Expected Earnings

GE HealthCare Technologies Inc. (NASDAQ:GEHC)’s stock price gapped up before the market opened on Wednesday after the company announced better than expected quarterly earnings. The stock had previously closed at $64.11, but opened at $69.32. GE HealthCare Technologies shares last traded at $71.8030, with a volume of 2,822,886 shares traded.

The company reported $1.13 earnings per share for the quarter, beating analysts’ consensus estimates of $1.04 by $0.09. GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.The business had revenue of $5.29 billion for the quarter, compared to analysts’ expectations of $5.26 billion. During the same quarter in the prior year, the business earned $1.06 EPS. The firm’s revenue for the quarter was up 5.8% on a year-over-year basis.

GE HealthCare Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 14th. Stockholders of record on Friday, July 24th will be given a $0.035 dividend. The ex-dividend date of this dividend is Friday, July 24th. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio is presently 3.35%.

Key Headlines Impacting GE HealthCare Technologies

Here are the key news stories impacting GE HealthCare Technologies this week:

• Positive Sentiment: GE HealthCare reported adjusted earnings of $1.13 per share, ahead of the $1.04 analyst consensus and up from $1.06 a year earlier. Revenue reached approximately $5.29 billion to $5.30 billion, slightly above the $5.26 billion estimate. GE HealthCare Technologies Beats Q2 Earnings and Revenue Estimates
• Positive Sentiment: Sales increased about 6%, while orders rose to a record high across every segment. Management said the order momentum, new-product adoption and record backlog demonstrate strong commercial execution and provide improved visibility for future revenue. GE HealthCare Reports Second Quarter 2026 Financial Results
• Positive Sentiment: Strong demand for diagnostic and imaging equipment supported the quarter, helping GE HealthCare exceed profit expectations. Tariff refunds also benefited earnings, adding to the reported profit upside. GE HealthCare Beats Quarterly Profit Estimates
• Neutral Sentiment: The company said it remains focused on returning its Patient Care Solutions business to growth and profitability and is reviewing strategy for that segment, indicating that performance is not uniformly strong across the portfolio. GE HealthCare Reports Second Quarter 2026 Financial Results
• Negative Sentiment: Part of the earnings benefit came from tariff refunds, which may be a one-time or nonrecurring factor. Investors will likely focus on whether the record orders and backlog translate into sustainable organic growth and margin improvement.

Wall Street Analyst Weigh In

Several analysts recently commented on GEHC shares. Mizuho reduced their target price on shares of GE HealthCare Technologies from $90.00 to $80.00 in a report on Thursday, April 30th. HSBC lowered their price target on shares of GE HealthCare Technologies from $100.00 to $90.00 in a report on Thursday, April 30th. UBS Group cut their price objective on shares of GE HealthCare Technologies from $69.00 to $67.00 and set a “neutral” rating for the company in a research report on Thursday, July 16th. Royal Bank Of Canada started coverage on GE HealthCare Technologies in a research report on Tuesday, June 23rd. They issued an “outperform” rating and a $80.00 target price on the stock. Finally, Evercore set a $80.00 target price on GE HealthCare Technologies in a research note on Thursday, April 30th. Ten investment analysts have rated the stock with a Buy rating, ten have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company has an average rating of “Hold” and an average target price of $76.41.

Insider Buying and Selling at GE HealthCare Technologies

In other GE HealthCare Technologies news, CFO James Saccaro acquired 3,310 shares of the business’s stock in a transaction on Friday, May 1st. The stock was purchased at an average price of $60.60 per share, with a total value of $200,586.00. Following the acquisition, the chief financial officer directly owned 87,471 shares of the company’s stock, valued at approximately $5,300,742.60. This trade represents a 3.93% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Kevin Lobo bought 10,000 shares of the firm’s stock in a transaction on Friday, May 22nd. The shares were acquired at an average price of $64.18 per share, for a total transaction of $641,800.00. Following the transaction, the director owned 14,363 shares in the company, valued at approximately $921,817.34. This represents a 229.20% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders purchased 21,847 shares of company stock valued at $1,361,355 in the last quarter. Company insiders own 0.36% of the company’s stock.

Institutional Investors Weigh In On GE HealthCare Technologies

A number of hedge funds and other institutional investors have recently made changes to their positions in GEHC. Laurel Wealth Advisors LLC bought a new stake in shares of GE HealthCare Technologies in the fourth quarter valued at approximately $26,000. Optima Capital LLC bought a new position in GE HealthCare Technologies during the 4th quarter worth $27,000. Godfrey Financial Associates Inc. acquired a new position in GE HealthCare Technologies in the 4th quarter valued at $27,000. Montag A & Associates Inc. raised its holdings in GE HealthCare Technologies by 105.4% in the 4th quarter. Montag A & Associates Inc. now owns 341 shares of the company’s stock valued at $28,000 after acquiring an additional 175 shares in the last quarter. Finally, Transamerica Financial Advisors LLC lifted its position in shares of GE HealthCare Technologies by 331.6% during the 4th quarter. Transamerica Financial Advisors LLC now owns 341 shares of the company’s stock valued at $28,000 after acquiring an additional 262 shares during the period. 82.06% of the stock is currently owned by institutional investors and hedge funds.

GE HealthCare Technologies Trading Up 11.9%

The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.95 and a current ratio of 1.22. The company has a market capitalization of $32.63 billion, a price-to-earnings ratio of 17.15, a price-to-earnings-growth ratio of 1.66 and a beta of 0.72. The firm has a fifty day moving average price of $63.68 and a 200-day moving average price of $70.80.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.